Tracking Intervention Effects With Eye Tracking



Status:Recruiting
Conditions:Neurology, Autism
Therapuetic Areas:Neurology, Psychiatry / Psychology
Healthy:No
Age Range:4 - 7
Updated:1/14/2018
Start Date:January 2016
End Date:September 2018
Contact:Erin MacDonnell
Email:erin.macdonnell@yale.edu
Phone:(203) 737-3439

Use our guide to learn which trials are right for you!

This pilot study examines concurrent and predictive relationships between eye tracking and
clinical outcomes during a 16-week behavioral intervention (PRT) for children with ASD. Eye
tracking will be comprised of both laboratory-based measures (using a commercial eye-tracking
system) as well as home-based measures (using tablet-based eye tracking systems). The major
goals of this study are both to improve our understanding of the potential role of eye
tracking in clinical trials and to advance technologies that may further improve the
sensitivity, robustness, accessibility, and ultimate utility of eye tracking methodologies.


Inclusion Criteria:

- Individuals ages 4-7 years diagnosed previously with ASD and meet criteria for ASD
when characterized by our research team, English is a language spoken in the family,
and Full-scale IQ>50. Participants must also complete laboratory and home-based eye
tracking sessions, with success determined by the Principal Investigator.

Exclusion Criteria:

- Individuals will be excluded from participation based on the presence of

1. a physical or neurological disorder (e.g., cerebral palsy) which is likely to
impact development and learning, as intervention procedures for these individuals
may need to be modified beyond the standard approach to address more complex
developmental needs,

2. hearing loss or other severe sensory impairment,

3. history of significant head trauma or serious brain or psychiatric illness,

4. parents/caregivers who do not speak fluent English,

5. parents/caregivers who have previous training in PRT

6. individuals who must be excluded from eye tracking. These families will be
offered the treatment clinically (i.e., fee-based), and they will be given
referrals to outside agencies offering the treatment as well.
We found this trial at
1
site
New Haven, Connecticut 06520
Principal Investigator: Frederick Shic, PhD
?
mi
from
New Haven, CT
Click here to add this to my saved trials